Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV000408591 | SCV000281791 | pathogenic | Severe early-childhood-onset retinal dystrophy | 2016-01-01 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001075348 | SCV001240968 | pathogenic | Retinal dystrophy | 2018-05-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000085658 | SCV001247768 | pathogenic | not provided | 2019-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000085658 | SCV001587236 | pathogenic | not provided | 2023-06-26 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 99305). This premature translational stop signal has been observed in individual(s) with ABCA4-related retinal disease (PMID: 29555955, 29925512). This variant is present in population databases (rs62645957, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Trp15*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). |
Retina International | RCV000085658 | SCV000117798 | not provided | not provided | no assertion provided | not provided |